Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Do healthy males aged 18 years and older show an effect of Bremelanotide on social cognition and behaviour?

Next Previous
X
Search
Trial Profile

Do healthy males aged 18 years and older show an effect of Bremelanotide on social cognition and behaviour?

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 05 Apr 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bremelanotide (Primary)
  • Indications Cognition disorders
  • Focus Therapeutic Use

    • Most Recent Events

    • 31 Mar 2021 Status changed from recruiting to completed.
    • 31 Mar 2021 Inclusion criteria is updated to increase the minimum age limit from 16 to 18 years.
    • 31 Mar 2021 Planned number of patients changed from 30 to 61.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top